Out to make a bigger difference, Alphabet’s Isomorphic Labs is exploring a much more useful application of AI. The Google ...

ICE Raids Derail Los Angeles Economy as Workers Go Into Hiding Texas Floods Inundate Central Areas As Waters Seen Rising ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

European technology companies are commanding attention on the global stage, with several securing massive funding rounds that ...

Isomorphic Labs sets up US presence in Cambridge, with an eye on clinical trials By Katie Palmer STAT,Updated June 17, 2025, 10:57 a.m.

Isomorphic Labs sets up U.S. presence, with an eye on clinical trials The Alphabet company, spun off from DeepMind, is hiring a new chief medical officer and adding an office in Cambridge ...

While Isomorphic is an independent unit of Google parent Alphabet, Hassabis' dual roles reflect the intertwined relationship between the two parties. Isomorphic has never revealed how much Google ...